# ResMed quarterly financial performance

> Developing situation record from CLSTR: https://clstr.news/situations/resmed-quarterly-financial-performance
> Updated: 2026-10-30T03:50:52.000Z. Sources: 5. Developments: 2.

ResMed reported strong financial results for the third quarter of 2026, with revenue reaching $1.41 billion. This figure represented a 5.9% year-on-year increase and exceeded analyst consensus estimates of $1.39 billion. The company reported non-GAAP adjusted earnings per share of $2.91, which was 8.9% above the expected $2.67. CEO Mick Farrell attributed this performance to global demand for breathing health solutions and proceeds from the divestiture of MatrixCare, though operating and free cash flow margins saw slight declines compared to the previous year.

In subsequent reporting, the company highlighted revenue of approximately $1.4 billion, a 6% increase from the previous year. Earnings per share rose 14%, defying earlier predictions of contraction. Mick Farrell attributed these results to gross margin appreciation and growth in the digital health ecosystem, noting milestones such as 36 million cloud-connected devices sold. ResMed also announced a partnership with Eight Sleep to integrate sleep tracking and confirmed it will maintain its quarterly dividend at $0.66 per share.

## Timeline

### 2026-10-30: ResMed reports strong quarterly earnings and dividend

ResMed exceeded quarterly forecasts with US$1.4 billion in revenue and a 14% rise in earnings per share, while maintaining its $0.66 quarterly dividend.

2 sources. https://clstr.news/cluster/resmed-reports-strong-quarterly-earnings-and-dividend

### 2026-10-28: ResMed reports Q3 revenue of $1.41 billion, beating analyst estimates

ResMed exceeded analyst expectations in Q3 2026, reporting $1.41 billion in revenue and $2.91 in adjusted earnings per share.

3 sources. https://clstr.news/cluster/resmed-reports-q3-revenue-of-141-billion-beating-analyst-estimates

---
Cite as: ResMed quarterly financial performance. CLSTR, https://clstr.news/situations/resmed-quarterly-financial-performance
